Issues in quantification of cardiac PET studies

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 3, 2007, Pages 316-319

  De Jong, Hugo W A M ^a   Lubberink, Mark ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; FLUORINE 18; FLUORODEOXYGLUCOSE; NITROGEN 13 AMMONIA; OXYGEN 15; PALMITIC ACID C 11; RUBIDIUM 82; TRACER; UNCLASSIFIED DRUG;

ALGORITHM; COMPUTED TOMOGRAPHY SCANNER; ECHOCARDIOGRAPHY; EDITORIAL; HUMAN; IMAGE QUALITY; KINETICS; LOW DRUG DOSE; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIOACTIVITY; THREE DIMENSIONAL IMAGING; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ALGORITHMS; CARDIOVASCULAR DISEASES; HEART; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES;

EID: 33847107135     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0283-3     Document Type: Editorial

References (42)

1. Jadvar H, Strauss HW, Segall GM. SPECT and PET in the evaluation of coronary artery disease. Radiographics 1999;19:915-26.
2. Paul AK, Nabi HA. Gated myocardial perfusion SPECT: basic principles, technical aspects, and clinical applications. J Nucl Med Technol 2004;32:179-87.
3. Bateman TM, Heller GV, Mcghie AI, Friedman JD, Case JA, Bryngelson JR, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 2006;13:24-33.
4. Sanchez-Crespo A, Andreo P, Larsson SA. Positron flight in human tissues and its influence on PET image spatial resolution. Eur J Nucl Med Mol Imaging 2004;31:44-51.
5. 18F-FDG PET. J Nucl Med 2005;46:2009-13.
6. DeGrado TR, Bergmann SR, Ng CK, Raffel DM. Tracer kinetic modeling in nuclear cardiology. J Nucl Cardiol 2000;7:686-700.
7. 2O production and injection system for PET imaging. Nucl Med Biol 1995;22:241-9.
8. 15O-water and dynamic positron emission tomography. Circulation 1992;86:167-78.
9. Camici P, Araujo L, Spinks T, Lammertsma AA, Jones T, Maseri A. Myocardial glucose utilization in ischaemic heart disease: preliminary results with F18-fluorodeoxyglucose and positron emission tomography. Eur Heart J 1986;7 Suppl C:19-23.
10. Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Schelbert HR, Nienaber CA, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and F-18 deoxyglucose. J Nucl Med 1989;30:359-66.
11. 11C]acetate and dynamic positron emission tomography. Circulation 1989;79:134-42.
12. Klein LJ, Visser FC, Knaapen P, Peters JH, Teule GJ, Visser CA, et al. Carbon-11 acetate as a tracer of myocardial oxygen consumption. Eur J Nucl Med 2001;28:651-68.
13. Bergmann SR, Weinheimer CJ, Markham J, Herrero P. Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med 1996;37:1723-30.
14. Knuuti J, Sipola P. Is it time for cardiac innervation imaging? Q J Nucl Med Mol Imaging 2005;49:97-105.
15. Stollfuss JC, Kosa I, Ziegler S, Schwaiger M. Quantitative assessment of myocardial perfusion: is it of clinical relevance? Q J Nucl Med 1996;40:76-84.
16. Knaapen P, Van Campen LM, De Cock CC, Gotte MJ, Visser CA, Lammertsma AA, et al. Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation 2004;110:646-51.
17. Yokoyama I, Ohtake T, Momomura S, Nishikawa J, Sasaki Y, Omata M. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation 1996;94:3232-8.
18. Schindler TH, Nitzsche EU, Schelbert HR, Olschewski M, Sayre J, Mix M, et al. Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J Am Coll Cardiol 2005;45:1505-12.
19. Sønderdgaard H, Madsen MM, Boisen K, Böttcher M, Schmitz O, Nielsen TT, et al. Evaluation of iterative reconstruction (OSEM) versus filtered back projection for the assessment of myocardial glucose uptake and myocardial perfusion using dynamic PET. Eur J Nucl Med Mol Imaging 2006 Oct 11 [Epub ahead of print]. DOI 10.1007/s00259-006-0198-z.
20. 82Rb myocardial perfusion PET imaging. J Nucl Med 2003;44:1350-6.
21. Votaw JR, White M. Comparison of 2-dimensional and 3-dimensional cardiac Rb-82 PET studies. J Nucl Med 2001;42:701-6.
22. Moisan C, Rogers JG, Douglas JL. A count rate model for PET and its application to an LSO HR PLUS scanner. IEEE Trans Nucl Sci 1997;44:1219-24.
23. Adam LE, Karp JS, Brix G. Investigation of scattered radiation in 3D whole-body positron emission tomography using Monte Carlo simulations. Phys Med Biol 1999;44:2879-95.
24. Zaidi H. Scatter modelling and correction strategies in fully 3-D PET. Nucl Med Commun 2001;22:1181-4.
25. 18F-FDG PET. J Nucl Med 2004;45:2008-15.
26. Sossi V, Oakes TR, Chan GLY, Schulzer M, Ruth TJ. Quantitative comparison of three- and two-dimensional PET with human brain studies. J Nucl Med 1998;39:1714-9.
27. 15O and 3-dimensional PET: an experimental validation. J Nucl Med 2002;43:1031-40.
28. Paans AM, Lamotte DW. Sensitivity and cross calibration. Eur J Nucl Med 1989;15:756-60.
29. Geworski L, Knoop BO, de Wit M, Ivancevic V, Bares R, Munz DL. Multicenter comparison of calibration and cross calibration of PET scanners. J Nucl Med 2002;43:635-9.
30. Westerterp M, Pruim J, Oyen WJG, Hoekstra OS, Paans AM, Visser EJ, et al. Quantification of FDG-PET studies using standardised uptake values in multicenter trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging. In press.
31. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med 2004;45:1519-27.
32. Boellaard R, Van Lingen A, Lammertsma AA. Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling. J Nucl Med 2001;42:808-17.
33. Krak NC, Boellaard R, Hoekstra OS, Twisk JW, Hoekstra CJ, Lammertsma AA. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial. Eur J Nucl Med Mol Imaging 2005;32:294-301.
34. van der Weerdt AP, Klein LJ, Visser CA, Visser FC, Lammertsma AA. Use of arterialised venous instead of arterial blood for measurement of myocardial glucose metabolism during euglycaemic-hyperinsulinaemic clamping. Eur J Nucl Med Mol Imaging 2002;29:663-9.
35. 18F-FDG PET scans. J Nucl Med 2001;42:1622-9.
36. Iida H, Rhodes CG, de Silva R, Araujo LI, Bloomfield PM, Lammertsma AA, et al. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med 1992;33:1669-77.
37. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.
38. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1990;10:740-7.
39. Blomqvist G. On the construction of functional maps in positron emission tomography. J Cereb Blood Flow Metab 1984;4:629-32.
40. Gunn RN, Gunn SR, Turkheimer FE, Aston JA, Cunningham VJ. Positron emission tomography compartmental models: a basis pursuit strategy for kinetic modeling. J Cereb Blood Flow Metab 2002;22:1425-39.
41. 15O-water and positron emission tomography. Mol Imaging Biol 2005;7:273-85.
42. 15O-water and PET using the basis function method. J Nucl Med 2005;46:1219-24.